Pharmacological approach to therapy of glomerulonephritis
Author
Source
Saudi Journal of Kidney Diseases and Transplantation
Issue
Vol. 6, Issue 4 (31 Aug. 1995), pp.387-395, 9 p.
Publisher
Saudi Center for Organ Transplantation
Publication Date
1995-08-31
Country of Publication
Saudi Arabia
No. of Pages
9
Main Subjects
Topics
Abstract EN
Since glomerulonephritis is a typical inflammation, we are approaching the time when inhibitors of the mediators of inflammation will be used to modify the course of nephritides.
In this category are thromboxane synthetase inhibitors and thromboxane antagonists as well as anti-leukotriene and anti-platelet activating factor agents.
Corticosteroids are often limited by their side effects.
Other approaches include the use of heparins, endothelin antagonists and E prostaglandins.
This article presents the background knowledge to these considerations.
American Psychological Association (APA)
Nigel Wardle, E.. 1995. Pharmacological approach to therapy of glomerulonephritis. Saudi Journal of Kidney Diseases and Transplantation،Vol. 6, no. 4, pp.387-395.
https://search.emarefa.net/detail/BIM-212366
Modern Language Association (MLA)
Nigel Wardle, E.. Pharmacological approach to therapy of glomerulonephritis. Saudi Journal of Kidney Diseases and Transplantation Vol. 6, no. 4 (December 1995), pp.387-395.
https://search.emarefa.net/detail/BIM-212366
American Medical Association (AMA)
Nigel Wardle, E.. Pharmacological approach to therapy of glomerulonephritis. Saudi Journal of Kidney Diseases and Transplantation. 1995. Vol. 6, no. 4, pp.387-395.
https://search.emarefa.net/detail/BIM-212366
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references : p. 390-395
Record ID
BIM-212366